148 related articles for article (PubMed ID: 26200223)
1. Preclinical imaging and treatment of cancer: the use of animal models beyond rodents.
Axiak-Bechtel SM; Maitz CA; Selting KA; Bryan JN
Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):303-16. PubMed ID: 26200223
[TBL] [Abstract][Full Text] [Related]
2. The role of companion animal models in radiopharmaceutical development and translation.
Maitz CA; Bryan JN
Vet Comp Oncol; 2024 Jun; 22(2):165-173. PubMed ID: 38439693
[TBL] [Abstract][Full Text] [Related]
3. [Current Status and Prospects on PET Radiopharmaceuticals for Radiotherapy].
Yoshimoto M
Igaku Butsuri; 2015; 35(1):10-5. PubMed ID: 26753391
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Pharmacokinetics and Dosimetry Studies of
Marsh IR; Grudzinski J; Baiu DC; Besemer A; Hernandez R; Jeffery JJ; Weichert JP; Otto M; Bednarz BP
J Nucl Med; 2019 Oct; 60(10):1414-1420. PubMed ID: 30926646
[TBL] [Abstract][Full Text] [Related]
5. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.
Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA
Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595
[TBL] [Abstract][Full Text] [Related]
6. Theranostics and Patient-Specific Dosimetry.
Bednarz B
Semin Radiat Oncol; 2023 Jul; 33(3):317-326. PubMed ID: 37331786
[TBL] [Abstract][Full Text] [Related]
7. Theranostic Imaging of Yttrium-90.
Wright CL; Zhang J; Tweedle MF; Knopp MV; Hall NC
Biomed Res Int; 2015; 2015():481279. PubMed ID: 26106608
[TBL] [Abstract][Full Text] [Related]
8. Canine anatomic phantom for preclinical dosimetry in internal emitter therapy.
Padilla L; Lee C; Milner R; Shahlaee A; Bolch WE
J Nucl Med; 2008 Mar; 49(3):446-52. PubMed ID: 18287264
[TBL] [Abstract][Full Text] [Related]
9. Translating Research for the Radiotheranostics of Nanotargeted
Chang CH; Chang MC; Chang YJ; Chen LC; Lee TW; Ting G
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918011
[TBL] [Abstract][Full Text] [Related]
10. Animal models of bone metastasis.
Rosol TJ; Tannehill-Gregg SH; LeRoy BE; Mandl S; Contag CH
Cancer; 2003 Feb; 97(3 Suppl):748-57. PubMed ID: 12548572
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of rapid dual-tracer (62)Cu-PTSM + (62)Cu-ATSM PET in dogs with spontaneously occurring tumors.
Black NF; McJames S; Rust TC; Kadrmas DJ
Phys Med Biol; 2008 Jan; 53(1):217-32. PubMed ID: 18182698
[TBL] [Abstract][Full Text] [Related]
12. A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.
Cui L; Lin Q; Jin CS; Jiang W; Huang H; Ding L; Muhanna N; Irish JC; Wang F; Chen J; Zheng G
ACS Nano; 2015; 9(4):4484-95. PubMed ID: 25830219
[TBL] [Abstract][Full Text] [Related]
13. Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs.
Miller C; Rousseau J; Ramogida CF; Celler A; Rahmim A; Uribe CF
Theranostics; 2022; 12(1):232-259. PubMed ID: 34987643
[TBL] [Abstract][Full Text] [Related]
14. Cancer nanotargeted radiopharmaceuticals for tumor imaging and therapy.
Ting G; Chang CH; Wang HE
Anticancer Res; 2009 Oct; 29(10):4107-18. PubMed ID: 19846958
[TBL] [Abstract][Full Text] [Related]
15. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
16. Copper radiopharmaceuticals for theranostic applications.
Ahmedova A; Todorov B; Burdzhiev N; Goze C
Eur J Med Chem; 2018 Sep; 157():1406-1425. PubMed ID: 30282317
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model.
Iguchi Y; Michiue H; Kitamatsu M; Hayashi Y; Takenaka F; Nishiki T; Matsui H
Biomaterials; 2015 Jul; 56():10-7. PubMed ID: 25934274
[TBL] [Abstract][Full Text] [Related]
18. Brain tumour and infiltrations dosimetry of boron neutron capture therapy combined with 252Cf brachytherapy.
Brandão SF; Campos TP
Radiat Prot Dosimetry; 2012 Apr; 149(3):289-96. PubMed ID: 21705767
[TBL] [Abstract][Full Text] [Related]
19. Radioactive Main Group and Rare Earth Metals for Imaging and Therapy.
Kostelnik TI; Orvig C
Chem Rev; 2019 Jan; 119(2):902-956. PubMed ID: 30379537
[TBL] [Abstract][Full Text] [Related]
20. Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia.
Vāvere AL; Lewis JS
Dalton Trans; 2007 Nov; (43):4893-902. PubMed ID: 17992274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
